Radiomics-based ultrasOund Model for differentiating Uterine Sarcomas from leiomyomas (ROMUS): a retrospective pilot
F Ciccarone1, A Rizzi1, A Biscione2
1Gynecologic Oncology Unit, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
Summary
Machine learning models incorporating radiomics features and patient age show promise in distinguishing uterine sarcomas from leiomyomas. This approach offers comparable sensitivity to expert assessment, aiding in gynecologic oncology diagnostics.
Area of Science:
- Gynecologic Oncology
- Medical Imaging
- Machine Learning
Background:
- Distinguishing uterine sarcomas from benign leiomyomas preoperatively is challenging.
- Accurate differentiation is crucial for appropriate patient management and treatment planning.
Purpose of the Study:
- To develop and evaluate machine-learning models for differentiating uterine sarcomas from leiomyomas.
- Incorporate clinical data and radiomics features from ultrasound images.
Main Methods:
- Retrospective case-control study of 200 patients (100 uterine sarcomas, 100 leiomyomas).
- Extracted radiomics features (intensity, texture) and patient age.
- Developed and validated logistic regression, random forest, extreme gradient boosting (XGBoost), and support vector machine models.
- Compared model performance against subjective assessments by ultrasound examiners.
Main Results:
- Eight statistically significant, non-redundant radiomics features were selected.
- An XGBoost model integrating patient age and radiomics achieved an AUC of 0.93, sensitivity of 0.93, and specificity of 0.83 in the validation set.
- Model performance was comparable to subjective assessments by original and expert ultrasound examiners.
Conclusions:
- A machine learning model combining radiomics features and patient age shows good performance in differentiating uterine sarcomas from leiomyomas.
- The model's sensitivity is higher than specificity, similar to expert subjective assessment.
- Further prospective studies are needed to confirm radiomics' role and explore integration into clinical practice.
